Date Added: 08/02/2017

Date Updated: 09/02/2017

ER-REBOA Catheter for resuscitative endovascular balloon occlusion of the aorta (REBOA)

Specialties: Cardiovascular disease & vascular surgery - Emergency care

Technology Type: Devices - Procedures

Stage of development: Other

Stage of EAA: Assessment Complete

Description, patients and keywords:

Resuscitative endovascular balloon occlusion of the aorta (REBOA) offers a small number of trauma patients improved survival with less physiological disturbance than current treatment options such as cross clamping the aorta.  Although poor outcomes were noted, treatment with the REBOA may be considered a treatment of last resort for patients with few options.

The ER-REBOATM Catheter received 510k approval from the United States Food and Drug Administration because of its similarity to other legally marketed devices. There are, however, no human studies published on this device. Therefore, the evidence included in this Technology Brief assessed the use of similar technologies to carry out resuscitative endovascular balloon occlusion of the aorta (REBOA).


This report is work in progress and should not be used for external distribution without permission from the originating agency. Users should be aware that reports are based on information available at the time of research and often on a limited literature search.